Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 5, 2002, Pages 542-552

  Fujita, Tadashi ^a   Maruyama, Muneharu ^a   Araya, Jun ^a   Sassa, Kazuhiko ^a   Kawagishi, Yukio ^a   Hayashi, Ryuji ^a   Matsui, Shoko ^a   Kashii, Tatsuhiko ^a   Yamashita, Naohiro ^a   Sugiyama, Eiji ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS;

EID: 0036846441     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4775     Document Type: Article

References (60)

1. nd Ed.). R. G. Crystal and J. B. West, editors. Lippincott-Raven, Philadelphia. 2251-2258.
2. Jackson, R. M. 1985. Pulmonary oxygen toxicity. Chest 88: 900-905.
3. Tate, R. M., H. G. Morris, W. R. Schroeder, and J. E. Repine. 1984. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J. Clin. Invest. 74:608-613.
4. Tate, R. M., K. M. Van Benthuysen, D. M. Shasby, I. F. McMurtry, and J. E. Repine. 1982. Oxygen radical mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am. Rev. Respir. Dis. 126:802-806.
5. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770-776.
6. Gorman, A., A. McGowan, and T. G. Cotter. 1997. Role of peroxide and superoxide anion during turnout cell apoptosis. FEBS Lett. 404:27-33.
7. Lee, B. R., and H.-D. Um. 1999. Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration. Exp. Cell Res. 248:430-438.
8. Gardner, A. M., F.-H. Xu, C. Fady, F. J. Jacoby, D. C. Duffey, Y. Tu, and A. Lichitenstein. 1997. Apoptotic and nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 22:73-83.
9. Hampton, M. B., and S. Orrenius. 1997. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett. 414:552-556.
10. Richter-Landsberg, C., and U. Vollgraf. 1998. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp. Cell Res. 244:218-229.
11. Banki, K., E. Hutter, N. J. Gonchoroff, and A. Perl. 1998. Molecular ordering in HIV-induced apoptosis: Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 273:11944-11953.
12. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. 1987. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-1673.
13. Griendling, K. K., and M. Ushio-Fukai. 1998. Redox control of vascular smooth muscle proliferation. J. Lab. Clin. Med. 132:9-15.
14. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
15. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
16. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
17. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91-101.
18. Hagimoto, N., K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko, and N. Hara. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-278.
19. Kuwano, K., H. Miyazaki, N. Hagimoto, M. Kawasaki, M. Fujita, R. Kunitake, Y. Kaneko, and N. Hara. 1999. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol. 20:53-60.
20. Sinclair, A. J., A. H. Barnett, and J. Lunec. 1990. Free radicals and antioxidant systems in health and disease. Br. J. Hosp. Med. 43:334-344.
21. Levine, A. J. 1997. P53, the cellular gatekeeper for growth and division. Cell 88:323-331.
22. Soldatenkov, V. A., and M. Smulson. 2000. Poly(ADP-ribose) polymerase in DNA damage-response pathway: Implications for radiation oncology. Int. J. Cancer 90:59-67.
23. Simbulan-Rosenthal, C. M., D. S. Rosenthal, R. Luo, and M. E. Smulson. 1999. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells. Cancer Res. 59:2190-2194.
24. Wang, X., K. Ohnishi, A. Takahashi, and T. Ohnishi. 1998. Poly(ADP- ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene 17:2819-2825.
25. Whitacre, C. M., H. Hashimoto, M. L. Tsai, S. Chatterjee, S. J. Berger, and N. A. Berger. 1995. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55:3697-3701.
26. Wafl/Cipl/Sdil and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154:477-483.
27. Kuwano, K., N. Hagimoto, T. Tanaka, M. Kawasaki, R. Kunitake, H. Miyazaki, Y. Kaneko, T. Matsuda, T. Maeyama, and N. Hara. 2000. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J. Pathol. 190:221-229.
28. Guinee, D., Jr., M. Fleming, T. Hayashi, M. Woodward, J. Zhang, J. Walls, M. Koss, V. Ferrans, and W. Travis. 1996. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am. J. Pathol. 149:531-538.
29. Hussain, M. Z., S. N. Giri, and R. S. Bhatnagar. 1985. Poly(ADP-ribose) synthetase activity during bleomycin-induce lung fibrosis in hamsters. Exp. Mol. Pathol. 43:162-176.
30. Nagai, A., H. Matsumiya, M. Hayashi, S. Yasui, H. Okamoto, and K. Konno. 1994. Effects of nicotinamide and niacin on bleomycin-induced acute injury and subsequent fibrosis in hamster lungs. Exp. Lung Res. 20:263-281.
31. Lehman, T. A., W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker, R. V. Modali, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, B. I. Gerwin, and C. C. Harris. 1991. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:4090-4096.
32. D'Ortho, M. P., C. Clerici, P. M. Yao, C. Delacourt, C. Delclaux, M. L. Franco-Montoya, A. Harf, and C. Lafuma. 1997. Alveolar epithelial cells in vitro produce gelatinases and tissue inhibitor of matrix metalloproteinase-2. Am. J. Physiol. 273:L663-L675.
33. Paul, E., D. I. Lee, S. W. Hyun, S. Gendler, and K. C. Kim. 1998. Identification and characterization of high molecular-mass mucin-like glycoproteins in the plasma membrane of airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 19:681-690.
34. Nambu, Y., S. J. Hughes, A. Rehemtulla, D. Hamstra, M. B. Orringer, and D. G. Beer. 1998. Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas. J. Clin. Invest. 101:1102-1110.
35. Agarwal, M. L., W. R. Taylor, M. V. Chernov, O. B. Chernova, and G. R. Stark. 1998. The p53 network. J. Biol. Chem. 273:1-4.
36. Biancone, L., A. D. Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi. 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186:147-152.
37. Eischen, C. M., C. J. Dick, and P. J. Leibson. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947-1954.
38. Aggarwal, B. B., S. Singh, R. LaPushin, and K. Totpal. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5-8.
39. Fine, A., N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico. 1997. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273:L64-L71.
40. Kuwano, K., N. Hagimoto, M. Kawasaki, N. Nakamura, K. Shirakawa, T. Maeyama, and N. Hara. 2000. Expression of FasL and Fas protein and their soluble form in patients with hypersensitivity pneumonitis. Int. Arch. Allergy Immunol. 122:209-215.
41. Baldwin, S. R., R. H. Simon, C. M. Grum, L. H. Ketai, L. A. Boxer, and L. J. Devall. 1986. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1:11-14.
42. Dekhuijzen, P. N. R., K. K. Aben, I. Dekker, L. P. Aarts, P. L. Wielders, C. L. Van Herwaarden, and A. Bast. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:813-816.
43. Loukides, S., I. Horvath, T. Wodehouse, P. J. Cole, and P. J. Barnes. 1998. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 158:991-994.
44. Baughman, R. P., B. C. Corser, S. Strohofer, and D. Hendricks. 1986. Spontaneous hydrogen peroxide release from alveolar macrophages of some cigarette smokers. J. Lab. Clin. Med. 107:233-237.
45. Baughman, R. P., E. E. Lower, G. Pierson, and S. Strohofer. 1988. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. J. Lab. Clin. Med. 111:399-404.
46. MacNee, W. 2000. Oxidants/antioxidants and COPD. Chest 117:303S-317S.
47. Järvinen, K., P. Pietarinen-Runtti, K. Linnainmaa, K. O. Raivio, C. M. Krejsa, T. Kavanagh, and V. L. Kinnula. 2000. Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells. Am. J. Physiol. 278:L696-L702.
48. Kazzaz, J. A., J. Xu, T. A. Palaia, L. Mantell, A. M. Fein, and S. Horowitz. 1996. Cellular oxygen toxicity: oxidant injury without apoptosis. J. Biol. Chem. 271:15182-15186.
49. Bardley, M. O., and L. C. Erickson. 1981. Comparison of the effects of hydrogen peroxide and x-ray irradiation on toxicity, mutation, and DNA damage/repair in mammalian cells (V-79). Biochim. Biophys. Acta 654:135-141.
50. Schraufstätter, I. U., D. B. Hinshaw, P. A. Hyslop, R. G. Spragg, and C. G. Cochrane. 1986. Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribosome polymerase and lead to delepletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77:1312-1320.
51. Bennett, M., K. Macdonald, S.-W. Chan, J. P. Luzio, R. Simari, and P. Weissberg. 1998. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science 282:290-293.
52. Sodeman, T., S. F. Bronk, P. J. Roberts, H. Miyoshi, and G. J. Gores. 2000. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am. J. Physiol. 278:G992-G999.
53. Stevens, C. F., and J. M. Sullivan. 1998. Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 21:885-893.
54. Chardin, P., and F. McCormick. 1999. Brefeldin A: The advantage of being uncompetitive. Cell 97:153-155.
55. Gamou, S., and N. Shimizu. 1995. Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett. 357:161-164.
56. 2 redox stress. Am. J. Respir. Cell Mol. Biol. 19:786-798.
57. 2 for platelet-derived growth factor signal transduction. Science 270:296-299.
58. Huang, C., Z. Zhang, M. Ding, J. Li, J. Ye, S. S. Leonard, H.-M. Shen, L. Butterworth, Y. Lu, M. Costa, Y. Rojanasakul, V. Castranova, V. Vallyathan, and X. Shi. 2000. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem. 275:32516-32522.
59. Kuwano, K., N. Hagimoto, M. Kawasaki, T. Yatomi, N. Nakamura, S. Nagata, T. Suda, R. Kunitake, T. Maeyama, H. Miyazaki, and N. Hara. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104:13-19.
60. Matute-Bello, G., W. C. Liles, K. P. Steinberg, P. A. Kiener, S. Mongovin, E. Y. Chi, M. Jonas, and T. R. Martin. 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163:2217-2225.